Pituitary tumor: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
{{Familytree/start}} | {{Familytree/start}} | ||
{{Familytree|boxstyle=background: #E0FFFF; | {{Familytree|boxstyle=background: #E0FFFF;| | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | |A01= Pituitary tumor }} | ||
{{Familytree|boxstyle=background: #E0FFFF;| | | | | | | | | | | | | {{Familytree|boxstyle=background: #E0FFFF;| | | | | | | | | | | | v | | | | | | | | | | | | | | |}} | ||
{{Familytree|boxstyle=background: #E0FFFF;| | | | | | | | | | | | | {{Familytree|boxstyle=background: #E0FFFF;| | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | B02 | | | | | | | | | | |B01= Anterior Pituitary Gland Tumors|B02= Posterior Pituitary Gland Tumors}} | ||
{{Familytree|boxstyle=background: #E0FFFF;| | |,|-|-|-|v|-|-|-|v|-|-|-|^|-|-|-|v|-|-|-|v|-|-|-|.| | | | |v | | | | | | | |}} | {{Familytree|boxstyle=background: #E0FFFF;| | |,|-|-|-|v|-|-|-|v|-|-|-|^|-|-|-|v|-|-|-|v|-|-|-|.| | | | |v | | | | | | | |}} | ||
{{Familytree|boxstyle=background: #E0FFFF;| | C01 | | C02 | | C03 | | | | | | C04 | | C05 | | C06 | | | C07 | | | | | | | | | | | |B01=[[Prolactinoma]]|B02=[[Corticotroph adenoma]]|B03=[[somatotroph adenomas]]|B04= [[thyrotroph adenomas]]|B05=[[Lymphoma]]|B06= [[Miscellaneous]]}} | {{Familytree|boxstyle=background: #E0FFFF;| | C01 | | C02 | | C03 | | | | | | C04 | | C05 | | C06 | | | C07 | | | | | | | | | | | |B01=[[Prolactinoma]]|B02=[[Corticotroph adenoma]]|B03=[[somatotroph adenomas]]|B04= [[thyrotroph adenomas]]|B05=[[Lymphoma]]|B06= [[Miscellaneous]]}} | ||
Revision as of 21:37, 16 December 2015
For patient information click here Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S.; Ammu Susheela, M.D. [2]
Overview
Classification
Pituitary tumors can be classified according to their pathological characteristics. The following variants can be distinguished (distribution over various subtypes may show regional variation):
- Papillary thyroid cancer (75%, incl. mixed papillary/follicular)
- Follicular thyroid cancer (16%)
- Medullary thyroid cancer (5-7%)
- Anaplastic thyroid cancer (3%)
- Lymphoma (1%)
- Squamous cell carcinoma, sarcoma (0.5 - 2%)
| Pituitary tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| {{{ v }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anterior Pituitary Gland Tumors | Posterior Pituitary Gland Tumors | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| {{{v }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| {{{ C01 }}} | {{{ C02 }}} | {{{ C03 }}} | {{{ C04 }}} | {{{ C05 }}} | {{{ C06 }}} | {{{ C07 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Follicular variant
Tall cell Diffuse sclerosing Encapsulated Columnar | Minimally invasive Overtly invasive | Small cell Giant cell | Sarcoma
Lymphoma Squamous cell carcinoma Mucoepidermoid carcinoma Plasma cell tumors Direct extension Kidney Melanoma Colon | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||